A Maryland woman has filed a lawsuit against Merck & Co., Inc., the manufacturer of Fosamax, alleging that she suffered two femur fractures after taking Fosamax for an extended period of time. Her suit joins others as part of the Fosamax mass tort underway in the Superior Court of New Jersey, Atlantic County Law Division. The filing of this lawsuit comes on the heels of an Indiana woman filing a similar claim, alleging that her use of Fosamax is responsible for her two broken femurs.
According to the lawsuit, the Maryland woman began taking Fosamax as prescribed in May 2002, and as a direct result of using the osteoporosis drug for a number of years, suffered two femur fractures. The suit says that Merck failed to warn to users about the risks of Fosamax, including research that suggests the drug can make bones brittle and vulnerable to fractures.
Long-Term Fosamax Use Might Be Responsible For Increase in Fractures
The controversy over how long osteoporosis patients should take a bisphosphonate drug like Fosamax has been heating up lately, in part because of an analysis performed by the U.S. Food and Drug Administration (FDA) that was published in May in the New England Journal of Medicine. The analysis found no strong evidence that bisphosphonates are useful after three to five years of treatment. Also published in May 2012 was a study by Swiss researchers that found 82 percent of patients with an atypical femur fracture had taken bisphosphonates.
Dr. Clifford J. Rosen, who co-authored an article agreeing with the FDA review, expressed the concern of many bisphosphonate users when he said, “How long they need to be on [bisphosphonates] is the biggest question. That’s what people want to know.” Dr. Rosen’s opinion is that a course of treatment lasting three-to-five years is best if “you haven’t had any fractures and bone density is better.”
Some in the medical community, including Jim Wright of the Therapeutics Initiative, take an even stronger stance on the drugs’ effectiveness. Wright believes, based on the evidence he’s reviewed, that “there are no clinically meaningful benefits for bisphosphonates in postmenopausal women” who haven’t experienced a fracture or other bone issues as a result of osteoporosis. “There’s really no proven benefit in women who just have a low bone mineral density. That’s probably the bulk of women who are getting it,” said Wright.
Osteoporosis Patients Should Consult a Physician About Fosamax
A drug like Fosamax can help those who are coping with bone loss. Very often, however, lifestyle changes such as dietary modifications and the addition of exercise can help strengthen bones and help reverse bone loss. Only a qualified medical professional, however, can advise whether osteoporosis can be treated without medication. It is important to weigh the risks and benefits of a drug like Fosamax in order to determine whether it is right for you.
RLG Represents Injured Fosamax Users
If you have been taking Fosamax for an extended period of time and have suffered a femur fracture, it could be because of the medication, and you might be eligible for compensation by filing a femur fracture lawsuit against Merck. The lawyers at the Rottenstein Law Group can help. Our lawyers have over 25 years of collective experience advocating for clients in consumer product injury and mass tort cases. Please fill out our confidential contact form, or call us at 1-877-332-2347, and one of our lawyers will be in touch.
For more information on Fosamax, download our free brochure.